Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03684629
Other study ID # CASE
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2018
Est. completion date December 31, 2023

Study information

Verified date November 2022
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Lou Min, Ph.D
Phone 8613738085675
Email loumingxc@vip.sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Study is designed for two parts, a perspective, multi-center, historial control study and a randomized controlled study of acute ischemic stroke patients. For achieving the target of diagnosis and treatment KPI (Key performance indicator) of AIS patients and improving the defects of the traditional working mode, our center developed the medical records data acquisition and KPI statistics system based on computer scan. This method guarantees the authenticity of the data, It computes the KPI of the corresponding medical institutions in the corresponding period and gives feedback on a regular basis. Based on the KPI feedback system, a multifaceted quality improvement intervention is conducted in the intervention group hospitals. This study aims to explore whether this new working mode can continuously improve the overall KPI in Zhejiang province, and thus reflect the improvement of quality and standardization of medical service in AIS patients.


Description:

Study population:patients with acute ischemic stroke who were admitted to the hospital within 7 days after the initial symptom onset. Program: There are multifaceted quality improvement interventions including: 1. Implementation of standardized templates of medical record, evidence-based clinical pathway, and written care protocols. 2. Feedback system of performance measures. 3. Expert online consultation. Endpoints: Primary outcome:increase of diagnosis and treatment key performance indicator for acute ischemic stroke patients; Secondary outcome: the occurrence of ischemic stroke, total mortality, disability, and new clinical vascular events.


Recruitment information / eligibility

Status Recruiting
Enrollment 16570
Est. completion date December 31, 2023
Est. primary completion date January 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - acute ischemic stroke or transient ischemic attacks patients Exclusion Criteria: - patients who losing his medical record of having the incomplete medical record

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
the response of KPI and corresponding suggestion
Standardized templates of medical record, evidence-based clinical pathway, and written care protocols are applied in all hospitals.The KPI of the AIS patients who were admitted to a single hospital continuously at the time of hospitalization were studied. Feedback system of performance measures: the hospital included in the study upload the medical records of all AIS patients by medical records scanning system since that month into the group. Quality control platform of Cerebral apoplexy in Zhejiang province extracts and analyze the data through the computer and calculates the corresponding monthly KPI. The hospitals will receive their own monthly KPI and the monthly highest KPI of all hospitals included in the study. Expert online consultation: based on the compare of the monthly KPI of all hospitals, Quality control platform will give corresponding suggestions to all hospitals for the improve of next month.

Locations

Country Name City State
China The second affiliated hosipital of Zhejiang University Zhejiang

Sponsors (18)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University First Affiliated Hospital of Wenzhou Medical University, Haining People's Hospital, Haiyan People's Hospital, Huizhou Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Lihuili Hospital of Ningbo Medical Center, Shaoxing People's Hospital, Taizhou First People's Hospital, Taizhou Hospital, Wenzhou Medical University, The First People's Hospital of Xiaoshan District, The Second Affiliated Hospital of Jiaxing University, Tiantai People's Hospital, Yiwu Central Hospital, Yongkang First People's Hospital, Yuyao People's Hospital, Zhoushan Hospital, Zhuji People's Hospital of Zhejiang Province

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of neurological deficit score the rate of the case number of cerebral infarction patients who have completed the National Institutes of Health Stroke Scale (NIHSS) at the time of admission in the total number of cerebral infarction patients hospitalized in the same period six month
Primary Rate of intravenous tPA within therapeutic time windows at symptom onset the rate of AIS patients who received intravenous recombinant tissue plasminogen activator (rt-pa) thrombolytic therapy within therapeutic time windows at symptom onset in patients with cerebral infarction six month
Primary Rate of administration of aspirin or other antiplatelet agents within 48 hours of admission The rate of patients who received aspirin or other antiplatelet agents within 48 hours of admission to the hospital in the total number of cerebral infarction patients hospitalized in the same period six month
Primary Rate of statin use during hospitalization The rate of patients hospitalized for cerebral infarction who were treated with statins in the total number of cerebral infarction patients hospitalized in the same period six month
Primary Rate of statin treatment at discharge The rate of patients with cerebral infarction who received statin at discharge in the total number of patients with non-cardiac infarction who were hospitalized in the same period six month
Primary Rate of antithrombotic therapy at discharge The rate of patients with cerebral infarction who received antithrombotic drugs (such as aspirin, other antiplatelet agents, heparin, warfarin or new oral anticoagulants) at discharge in the total number of hospitalized patients with cerebral infarction in the same period. six month
Primary Rate of anticoagulant treatment for patients with atrial fibrillation at discharge The rate of patients with cerebral infarction complicated with atrial fibrillation who received anticoagulants (e.g., heparin, low molecular heparin, warfarin, new oral anticoagulants) at discharge in the total number of patients with cerebral infarction complicated with atrial fibrillation treated in hospital in the same period six month
Primary a composite measure score of performance measures a composite measure score, defined as the total number of interventions performed among eligible patients divided by the total number of possible interventions among eligible patients, were also calculated. participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Primary a all-or-none measure of evidence-based performance measures the all-or-none measure was defined as the proportion of patients who received all of the performance measures for which the patient was eligible. participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Secondary Rate of prevention of deep vein thrombosis The rate of patients who were unable to get out of bed for cerebral infarction within 48 hours of admission that were given prophylactic measures including heparin and/or DVT (Deep vein thrombosis) in patients who were unable to get out of bed for cerebral infarction treated in hospital in the same period six month
Secondary Rate of blood vessel assessment within one week of hospitalization The rate of patients with cerebral infarction hospitalized for 1 week who had completed the evaluation of the blood vessels in the neck and cranial (such as the ultrasound of the blood vessels in the neck or cranial, CT or MR angiography, or DSA) in the total number of cerebral infarction patients hospitalized in the same period six month
Secondary Rate of swallowing function evaluation The rate of patients who had a history of drinking water test in the total number of stroke patients who were hospitalized in the same period. six month
Secondary Rate of lipid level assessment The rate of the number of patients who were assessed on lipid level during hospitalization in the total number of patients who were hospitalized during the same period. six month
Secondary Rate of rehabilitation evaluation and implementation The rate of cerebral infarction patients who received rehabilitation evaluation and implementation during the hospital period (48 hours after the patient's condition was stable) in the total number of patients who were hospitalized during the same period. six month
Secondary Rate of offerring quit smoking counseling or health benefits education The rate of patients who received smoking cessation counseling or health benefits education during hospitalization in total number of patients with cerebral infarction who were hospitalized during the same period six month
Secondary Rate of antihypertensive therapy for cerebral infarction patients with hypertension at discharge The rate of patients with cerebral infarction complicated with hypertension who were given antihypertensive drugs at discharge in the total number of patients with cerebral infarction complicated with hypertension who were hospitalized in the same period six month
Secondary Rate of Patients with diabetes were given hypoglycemic drug treatment at discharge The rater of patients with cerebral infarction complicated with diabetes who were given hypoglycemic drugs at discharge in the total number of patients with cerebral infarction complicated with diabetes treated in hospital in the same period six month
Secondary Average day in hospital The rate of the total number of days in hospital to the total number of patients with cerebral infarction in the same period six month
Secondary Averaged hospital costs Ratio of total hospital drug costs to total number of patients with cerebral infarction in the same period six month
Secondary Percentage of new clinical vascular events New clinical vascular events are defined as ischemic stroke, myocardial infarction, or peripheral arterial disease at discharge, 1-year after initial symptom onset. 1-year
Secondary Distribution of Modified Rankin Score Distribution of Modified Rankin Score at discharge, 1-year after initial symptom onset. At discharge
Secondary Distribution of Modified Rankin Score Distribution of Modified Rankin Score at discharge, 1-year after initial symptom onset. 1-year
Secondary Severe neurological deficits mRS score of 5-6 at discharge At discharge
Secondary Lipid-lowering to LDL >100 mg/dL The rate of lipid lowering for patients with Low-density lipoprotein (LDL) =100 mg/dL at discharge at discharge